1 |
Abumrad, N., Coburn, C. and Ibrahimi, A. 1999. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPpm. Biochem. Biophys. Acta. 1441, 4-13.
|
2 |
Berryman, D. E., Glad, C. A., List, E. O. and Johannsson, G. 2013. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat. Rev. Endocrinol. 9, 346-356.
DOI
|
3 |
Bonen, A., Campbell, S. E., Benton, C. R., Chabowski, A., Coort, S. L. M., Han, X., Koonen, D. P. Y., Glatz, J. F. C. and Luiken, J. J. F. P. 2004. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc. Nutr. Soc. 63, 245-249.
DOI
|
4 |
Bonen, A., Han, X. X., Habets, D. D., Febbraio, M., Galtz, J. J. and Luiken J. J. 2007. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. 292, E1740-E1749.
|
5 |
Bonen, A., Luiken, J. J., Liu, S., Dyck, D. J., Kiens, B., Kristiansen, S. and Turcotte, L. P. 1998. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. 275, E471-E478.
|
6 |
Bonen, A., Parolin, M. L., Steingerg, G. R., Calles-Escandon, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., Heigenhauser, G. J. F. and Dyck, D. J. 2004. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18, 1144-1146.
|
7 |
Brinkamann, J. F. F., Abumrad, N. A., Ibrahimi, A., Van Der Vusse, G. J. and Glatz, J. F. C. 2002. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem. J. 367, 561-570.
DOI
|
8 |
Clarke, D. C., Miskovic, D., Han, X., Calles-Escandon, J., Glatz, J. F. C., Luiken, J. J. F. P., Heikkila, J. J. and Bonen, A. 2004. Overexpression of memebrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics 17, 31-37.
DOI
|
9 |
Clemmons, D. R. 2004. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J. Clin. Invest. 113, 25-27.
DOI
|
10 |
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L. and Abumrad, N. A. 2000. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275, 32523-32529.
DOI
|
11 |
Coen, P. M. and Goodpaster, B. H. 2012. Role of intramyocelluar lipids in human health. Trends. Endocrinol. Metab. 23, 391-398.
|
12 |
Falholt, K., Jensen, I., Lindkaer Jensen, S., Mortensen, H., Volund, A., Heding, L. G., Noerskov Petersen, P. and Falholt, W. 1998. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet. Med. 5, 27-31.
|
13 |
Febbraio, M., Hajjar, D. P. and Silverstein, R. L. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108, 785-791.
DOI
|
14 |
Frystyk, J. Ledet, T. Moller, N. Flyvbjerg, A. and Orskov, H. 2002. Cardiovascular disease and insulin-like factor-Ⅰ. Circulation 106, 893-895.
DOI
|
15 |
Keizer, H. A., Schaart, G., Tandon, N. N., Glatz, J. F. C. and Luiken, J. J. F. P. 2004. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem. Cell. Biol. 121, 101-107.
DOI
|
16 |
Glatz, J. F. C., Luiken, J. J. F. P. and Bonen, A. 2001. Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. J. Mol. Neurosci. 16,123-132.
DOI
|
17 |
Glatz, J. F. C., Luiken, J. J. F. P. and Bonen, A. 2010. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic, disease. Physiol. Rev. 90, 367-417.
DOI
|
18 |
Jordy, A. B. and Kiens, B. 2014. Regulation of exercise-induced lipid metabolism in skeletal muscle. Exp. Physiol. 99, 1586-1592.
DOI
|
19 |
Le Roith, D. 1997. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N. Engl. J. Med. 336, 633-640.
DOI
|
20 |
Luiken, J. J., Coort, S. L., Koonen, D. P., van der Horst, D. J., Bonen, A., Zorzano, A. and Glatz, J. F. C. 2004. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers. Arch. 448, 1-15.
DOI
|
21 |
Machida, S. and Booth, F. W. 2004. Insulin-like growth factor 1 and muscle growth: implication for satellite cell proliferation. Proc. Nutr. Soc. 63, 337-340.
DOI
|
22 |
Moses, A. C., Young, S. C., Morrow, S. A., O′Brien, M. and Clemmons, D. R. 1996. Recombinant human insulin-like growth factor-I increases insulin sensitivity and improves glycemic control in type Ⅱ diabetes. Diabetes 45, 91-100.
DOI
|
23 |
Phillips, S. M. 2007. Resistance exercise: good for more than just grandma and grandpa′s muscles. Appl. Physiol. Nutr. Metab. 32, 1198-1205.
DOI
|
24 |
Van Nieuwenhoven, F. A., Verstijnen, C. P., Abumrad, N. A., Willemsen, P. H., Van Eys, G. J., Van der Vusse, G. J.and Glatz, J. F. C. 1995. Putative membrane fatty acid translocase and cytoplasmic fatty acid binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun. 207, 747-752.
DOI
|
25 |
Schneider, D. J. and Sobel, B. E. 1991. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type Ⅰ: implications for vascular disease in hyperinsulinemic states. Proc. Natl. Acad. Sci. USA 88, 9959-9963.
DOI
|
26 |
Schultz, E. and McCormick, K. M. 1994. Skeletal muscle satellite cells. Rev. Physiol. Biochem. Pharmacol. 123, 213-257.
|
27 |
van Loon, L. J., Koopman, R., Stegen, J. H. C. H., Wagenmakers, A. J. M., Keizer, H. A. and Saris, W. H. M. 2003. Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fated state. J. Physiol. 553, 611-625.
DOI
|